JNCI Cancer Spectrum, published by Oxford University Press, is a leading open-access journal dedicated to advancing the field of cancer research and oncology. With an impressive impact demonstrated through its Q1 ranking in both Cancer Research and Oncology categories for 2023, this journal provides a vital platform for disseminating high-quality research and innovative findings in a rapidly evolving landscape. Since its inception in 2017, JNCI Cancer Spectrum has embraced open access, enhancing the accessibility of evidence-based knowledge to researchers, professionals, and students across the globe. Additionally, it boasts notable positions in Scopus rankings, with a strong performance in both the Medicine and Biochemistry, Genetics and Molecular Biology categories. The journal is committed to its objectives of fostering collaborative efforts and encouraging dialogue among experts, making it an essential resource for anyone involved in cancer research.

AIDS Education and Prevention is a distinguished journal dedicated to the exploration of strategies for HIV/AIDS education, prevention, intervention, and policy. Published by Guilford Publications Inc, this journal has been a pivotal resource in the fields of Health (social science), Infectious Diseases, Medicine, and Public Health since its inception in 1989, and continues to be influential through 2024. With its respectable placement in the Q2 category across multiple disciplines, it offers high-impact research and practical insights that are essential for researchers, healthcare professionals, and students alike. Although not an Open Access journal, its compelling content and strict peer-review processes ensure that published works maintain high academic standards. The journal's contributions are integral in addressing the challenges surrounding HIV prevention and education, fostering a deeper understanding and knowledge that can lead to effective community responses.

JAIDS - Journal of Acquired Immune Deficiency Syndromes, is a leading peer-reviewed journal published by Lippincott Williams & Wilkins, focusing on the dynamics of HIV/AIDS and its broader implications in the fields of infectious diseases and pharmacology. With an esteemed impact factor that places it in the prestigious Q1 category for both Infectious Diseases and Pharmacology (medical) as of 2023, this journal aims to provide a platform for groundbreaking research, clinical findings, and innovative therapies relevant to the management and prevention of HIV/AIDS. The journal's rigorous editorial standards and commitment to advancing knowledge make it an essential resource for researchers, healthcare professionals, and students invested in the global response to AIDS. Although the journal does not currently offer open access options, it remains instrumental in disseminating high-quality research that shapes clinical practices and policy developments in the field.

Journal of Correctional Health Care, published by Mary Ann Liebert, Inc, is a vital publication that addresses the crucial intersection of health care, justice systems, and public health. With ISSN 1078-3458 and E-ISSN 1940-5200, this journal has been a leading source of research and analysis in correctional health since its inception in 1994. As of 2023, it holds an esteemed ranking within the Q2 quartile for Community and Home Care and Q3 for Public Health, Environmental and Occupational Health, reflecting its significant contribution to these fields. The Journal of Correctional Health Care focuses on the healthcare needs of incarcerated populations, providing a platform for innovative research, comprehensive reviews, and policy analysis. Researchers, professionals, and students alike will find invaluable insights that bridge gaps in knowledge and practice, emphasizing the importance of equitable health care within correctional settings. This journal continues to shape discussions and influence practices aimed at enhancing health outcomes in these vulnerable communities.

JCO Global Oncology is a premier open-access journal published by Lippincott Williams & Wilkins, dedicated to the dissemination of high-quality research in the fields of cancer research and oncology. Since its inception in 2020, this journal has rapidly established itself as a vital resource for researchers, healthcare professionals, and students, holding a distinguished position in the Q2 category for both Cancer Research and Oncology based on the latest metrics. With an impressive Scopus rank of #61 out of 636 in General Medicine, the journal is recognized for its rigorous peer-reviewed articles and cutting-edge insights into oncological science. The open-access model ensures that vital research is readily available to a global audience, fostering collaborative advancements in the fight against cancer. JCO Global Oncology explores a broad range of topics and encourages submissions that contribute to the understanding, prevention, and treatment of various malignancies. With its substantial impact and ongoing contributions to the field, it stands as a promising platform for advancing oncological discourse and knowledge.

AIDS AND BEHAVIOR, published by SPRINGER/PLENUM PUBLISHERS, is a leading scholarly journal dedicated to the interdisciplinary study of HIV/AIDS, focusing particularly on the behavioral aspects of the epidemic. With an impressive impact factor reflected in its Q1 rankings across key categories including Infectious Diseases, Public Health, and Social Psychology, this journal serves as a vital resource for researchers, clinicians, and public health professionals. It encompasses a wide scope of research, from the psychosocial factors influencing HIV transmission to innovative interventions that promote safe practices. Although it does not offer open access, the journal's rigorous peer-review process ensures the dissemination of high-quality, impactful research. Covering data from 1997 to 2024, AIDS AND BEHAVIOR is positioned at the forefront of advancements in the field, making it an essential addition to any academic library and a must-read for those involved in combating HIV/AIDS.

Welcome to the Cardiovascular Journal of Africa, an esteemed publication dedicated to advancing the fields of Cardiology and Cardiovascular Medicine. Established in 1994 and published by CLINICS CARDIVE PUBL PTY LTD, this journal serves as a vital platform for researchers, practitioners, and students interested in innovative cardiovascular research and clinical practice within the African context and beyond. With a Q3 ranking in both relevant categories as of 2023, this journal contributes significantly to the growing corpus of medical literature. Although access is non-open, the journal features a diverse array of peer-reviewed articles that explore groundbreaking findings and practical applications in cardiovascular health, fostering knowledge exchange among professionals. Situated in South Africa, the Cardiovascular Journal of Africa is not just a repository of academic research; it is a cornerstone in the fight against cardiovascular diseases, addressing the unique challenges faced by populations across the continent.

AIDS REVIEWS, published by Permanyer Publishing, is a distinguished academic journal dedicated to providing comprehensive insights into the field of AIDS research. Since its inception in 2000, the journal has served as a vital platform for disseminating knowledge on various aspects of HIV/AIDS, including prevention, treatment advancements, and socio-medical implications. With a commendable Q3 ranking in both Infectious Diseases and Medicine (miscellaneous), as well as Pharmacology (medical) in 2023, the journal has made significant strides in the academic community, covering relevant topics and emerging trends up to 2024. Although not open access, AIDS REVIEWS continues to attract contributions from leading researchers and professionals, fostering a collaborative environment aimed at improving health outcomes related to AIDS. Located in Barcelona, Spain, this journal is an essential resource for anyone dedicated to advancing their understanding of this global health challenge.

Current Opinion in HIV and AIDS is a pivotal journal published by Lippincott Williams & Wilkins, dedicated to the dissemination of cutting-edge research and insights in the rapidly evolving fields of HIV and AIDS. Established in 2007 and maintaining a comprehensive focus through to 2024, this journal has achieved an impressive position within academia, earning a Q1 ranking in multiple categories, including Hematology, Immunology, Infectious Diseases, Oncology, and Virology as of 2023, indicative of its high impact and relevance. Researchers and professionals benefit from its curated reviews that synthesize current knowledge, highlight emerging trends, and address clinical applications. While the journal is not open access, it remains a vital resource housed in prestigious databases, ensuring that vital information reaches a broad audience. The ISSN for print is 1746-630X and its E-ISSN is 1746-6318. Located in Philadelphia, PA, the journal's commitment to innovation and education makes it an essential platform for those engaged in combating one of the most pressing health challenges of our time.

Current HIV/AIDS Reports, published by Springer, is a distinguished scholarly journal that addresses critical developments in the field of HIV/AIDS research. As a leading publication within the Q1 quartiles for both Infectious Diseases and Virology, it serves as an essential platform for researchers and healthcare providers aiming to advance knowledge and practices related to HIV prevention, treatment, and care. With a commitment to publishing innovative studies, reviews, and clinical guidelines, this journal fosters a comprehensive understanding of the complexities surrounding HIV/AIDS. The journal enjoys a robust reputation, evidenced by its impressive Scopus rankings, including a rank of #69 in Infectious Diseases and #21 in Virology, placing it in the top echelons of its field. With an open-access model, *Current HIV/AIDS Reports* significantly enhances the accessibility of crucial research findings to a global audience, driving progress in HIV/AIDS knowledge and public health.